Previous Article | Next Article 
Journal of Virology, October 2003, p. 10769-10779, Vol. 77, No. 20
0022-538X/03/$08.00+0 DOI: 10.1128/JVI.77.20.10769-10779.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Cytopathic and Noncytopathic Interferon Responses in Cells Expressing Hepatitis C Virus Subgenomic Replicons
Ju-Tao Guo, Qing Zhu, and Christoph Seeger*
Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111
Received 25 April 2003/
Accepted 22 July 2003
Hepatitis C virus (HCV) is the only known positive-stranded RNA virus that causes persistent lifelong infections in humans. Accumulation of HCV RNA can be inhibited with alpha interferon (IFN-
) in vivo and in culture cells. We used cell-based assay systems to investigate the mechanisms responsible for the cytokine-induced inhibition of HCV replication. The results showed that IFN-
could suppress the accumulation of viral RNA by a noncytopathic pathway and could also induce apoptosis of virally infected cells in a concentration- and cell line-dependent fashion. Whereas the noncytopathic IFN-
response depended on a functional Jak-STAT signal transduction pathway, it did not appear to require double-stranded RNA-dependent pathways. Moreover, we found that functional proteasomes were required for establishment of the IFN-
response against HCV. Based on the results described in this study we propose a model for the mechanism by which IFN-
therapy suppresses HCV replication in chronic infections by both cytopathic and noncytopathic means.
* Corresponding author. Mailing address: Institute for Cancer Research, Fox Chase Cancer Center, 7701 Burholme Ave., Philadelphia, PA 19111. Phone: (215) 718-4312. Fax: (215) 728-4329. E-mail:
c_seeger{at}fccc.edu.
Journal of Virology, October 2003, p. 10769-10779, Vol. 77, No. 20
0022-538X/03/$08.00+0 DOI: 10.1128/JVI.77.20.10769-10779.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Chang, J., Guo, J.-T., Jiang, D., Guo, H., Taylor, J. M., Block, T. M.
(2008). Liver-Specific MicroRNA miR-122 Enhances the Replication of Hepatitis C Virus in Nonhepatic Cells. J. Virol.
82: 8215-8223
[Abstract]
[Full Text]
-
Jiang, D., Guo, H., Xu, C., Chang, J., Gu, B., Wang, L., Block, T. M., Guo, J.-T.
(2008). Identification of Three Interferon-Inducible Cellular Enzymes That Inhibit the Replication of Hepatitis C Virus. J. Virol.
82: 1665-1678
[Abstract]
[Full Text]
-
Evans, J. D., Seeger, C.
(2007). Differential Effects of Mutations in NS4B on West Nile Virus Replication and Inhibition of Interferon Signaling. J. Virol.
81: 11809-11816
[Abstract]
[Full Text]
-
Chang, K.-O., George, D. W.
(2007). Bile Acids Promote the Expression of Hepatitis C Virus in Replicon-Harboring Cells. J. Virol.
81: 9633-9640
[Abstract]
[Full Text]
-
Dahari, H., Ribeiro, R. M., Rice, C. M., Perelson, A. S.
(2007). Mathematical Modeling of Subgenomic Hepatitis C Virus Replication in Huh-7 Cells. J. Virol.
81: 750-760
[Abstract]
[Full Text]
-
Escuret, V., Martin, A., Durantel, D., Parent, R., Hantz, O., Trepo, C., Menguy, T., Bottius, E., Dardy, J., Maral, J., Escary, J. L., Zoulim, F.
(2006). Novel Alpha Interferon (IFN-{alpha}) Variant with Improved Inhibitory Activity against Hepatitis C Virus Genotype 1 Replication Compared to IFN-{alpha}2b Therapy in a Subgenomic Replicon System. Antimicrob. Agents Chemother.
50: 3984-3991
[Abstract]
[Full Text]
-
Chang, K.-S., Cai, Z., Zhang, C., Sen, G. C., Williams, B. R. G., Luo, G.
(2006). Replication of Hepatitis C Virus (HCV) RNA in Mouse Embryonic Fibroblasts: Protein Kinase R (PKR)-Dependent and PKR-Independent Mechanisms for Controlling HCV RNA Replication and Mediating Interferon Activities.. J. Virol.
80: 7364-7374
[Abstract]
[Full Text]
-
Ludmerer, S. W., Graham, D. J., Boots, E., Murray, E. M., Simcoe, A., Markel, E. J., Grobler, J. A., Flores, O. A., Olsen, D. B., Hazuda, D. J., LaFemina, R. L.
(2005). Replication Fitness and NS5B Drug Sensitivity of Diverse Hepatitis C Virus Isolates Characterized by Using a Transient Replication Assay. Antimicrob. Agents Chemother.
49: 2059-2069
[Abstract]
[Full Text]
-
Guo, J.-T., Hayashi, J., Seeger, C.
(2005). West Nile Virus Inhibits the Signal Transduction Pathway of Alpha Interferon. J. Virol.
79: 1343-1350
[Abstract]
[Full Text]
-
Liu, W. J., Wang, X. J., Mokhonov, V. V., Shi, P.-Y., Randall, R., Khromykh, A. A.
(2005). Inhibition of Interferon Signaling by the New York 99 Strain and Kunjin Subtype of West Nile Virus Involves Blockage of STAT1 and STAT2 Activation by Nonstructural Proteins. J. Virol.
79: 1934-1942
[Abstract]
[Full Text]
-
Kato, T., Date, T., Miyamoto, M., Zhao, Z., Mizokami, M., Wakita, T.
(2005). Nonhepatic Cell Lines HeLa and 293 Support Efficient Replication of the Hepatitis C Virus Genotype 2a Subgenomic Replicon. J. Virol.
79: 592-596
[Abstract]
[Full Text]
-
Liu, W. J., Chen, H. B., Wang, X. J., Huang, H., Khromykh, A. A.
(2004). Analysis of Adaptive Mutations in Kunjin Virus Replicon RNA Reveals a Novel Role for the Flavivirus Nonstructural Protein NS2A in Inhibition of Beta Interferon Promoter-Driven Transcription. J. Virol.
78: 12225-12235
[Abstract]
[Full Text]
-
Sumpter, R. Jr., Wang, C., Foy, E., Loo, Y.-M., Gale, M. Jr.
(2004). Viral Evolution and Interferon Resistance of Hepatitis C Virus RNA Replication in a Cell Culture Model. J. Virol.
78: 11591-11604
[Abstract]
[Full Text]
-
Mehta, A. S., Gu, B., Conyers, B., Ouzounov, S., Wang, L., Moriarty, R. M., Dwek, R. A., Block, T. M.
(2004). {alpha}-Galactosylceramide and Novel Synthetic Glycolipids Directly Induce the Innate Host Defense Pathway and Have Direct Activity against Hepatitis B and C Viruses. Antimicrob. Agents Chemother.
48: 2085-2090
[Abstract]
[Full Text]
-
Robek, M. D., Boyd, B. S., Wieland, S. F., Chisari, F. V.
(2004). Signal transduction pathways that inhibit hepatitis B virus replication. Proc. Natl. Acad. Sci. USA
101: 1743-1747
[Abstract]
[Full Text]